TARC Research Publications PDF Print E-mail

Supported by the contributions of more than two dozen researchers at five leading Texas medical research institutions, the Texas Alzheimer's Research Consortium (TARC) conducts advanced research on the genetic, biomarker and neuropsychological aspects of Alzheimer's disease (AD) in an attempt to achieve breakthroughs in detection, treatment, slowing progression and prevention of AD.

TARC e-bulletins
View the quarterly TARC e-bulletin on the latest developments in Alzheimer's research in Texas.
June 2009
April 2009

Research Publications Access all publications authored by TARC researchers on PubMed.

Read the latest publications from the Texas Alzheimer's Research Consortium. 

MANUSCRIPTS


TARC AUTHORS

TITLE

RESEARCH JOURNAL

Sid E. O’Bryant, Guanghua Xiao, Robert Barber, Stephen Waring, Joan Reisch, Rachelle Doody, Thomas Fairchild, Perrie Adams, & Ramon Diaz-Arrastia for the Texas Alzheimer’s Research Consortium.

A Serum Protein-Based Diagnostic Algorithm for the Detection of Alzheimer’s Disease

Archives of Neurology 2010, in press.

 

O’Bryant, SE, Hobson, V, Hall, J, Massman, P, Diaz-Arrastia.

Decreased CRP in Alzheimer’s Disease

Journal of Geriatric Psychiatry and Neurology 2010, in press.

Hobson, VL, Hall, J, Cullum, CM, Lacritz, L, Massman, P, Warring, S, O’Bryant, SE.

The Boston Naming Test: Calculation and utilization of an “estimated” 60-item score from 30- and 15-item administrations

Archives of Clinical Neuropsychology 2010, in press.

 

O’Bryant, SE, Hobson, V, Hall, J, Lacritz, L, Massman, P, Cullum, M, Diaz-Arrastia, R.

Brain-derived neurotropic factor (BDNF) in Alzheimer’s disease. A project of the Texas Alzheimer’s Research Consortium (TARC)

Journal of Alzheimer’s Disease 2009; 17:1051-1055.

Hobson VL, O’Bryant SE, Hall J, Cullum M, Lacritz L, Massman P, Waring SC for the Texas Alzheimer’s Research Consortium

Serum BDNF and Alzheimer’s Disease Severity: An investigation by the Texas Alzheimer’s Disease Research Consortium

Archives of Clinical Neuropsychology 2008; 23:674.

 

O’Bryant SE, Hobson VL, Hall J, Cullum M, Lacritz L, Massman P, Waring SC, Schiffer R for the Texas Alzheimer’s Research Consortium

Peripheral Inflammation and Neuropsychological Test Performance: An Investigation by the Texas Alzheimer’s Disease Research Consortium

Archives of Clinical Neuropsychology 2008; 23:673.

 

O’Bryant SE, Waring SC, Cullum CM, Hall JR, Lacritz LH, Massman PJ, Doody RS, Lupo P, Reisch J and the Texas Alzheimer’s Research Consortium

Staging Dementia Severity with CDR Sum of Box Scores: An investigation by the Texas Alzheimer’s Disease Research Consortium

Archives of Neurology 2008; 65:1091-1095.

 

O’Bryant SE, Grammas P.

A Case for the Creation of a Biomarker-Based Algorithm for the Detection of Alzheimer’s Disease

Journal of the Texas Public Health Association 2008; 63:14-17.

 

Waring SC, O'Bryant SE, Reisch J, Diaz-Arrastia R, Knebl J, Doody RS for the Texas Alzheimer’s Research Consortium

The Texas Alzheimer’s Research Consortium Longitudinal Research Cohort:  Study Design and Baseline Characteristics

Journal of the Texas Public Health Association 2008; 63:9-13.

 

Hall JR, Schiffer RB, O'Bryant SE.

Depression and Alzheimer’s Disease

Journal of the Texas Public Health Association 2008; 63:25-29.

 

O'Bryant SE, Hall JR, Waring SC, Humphreys JD, Hobson V, Schiffer RB.

The Relationship Between Cardiovascular Disease and AD

Journal of the Texas Public Health Association 2008; 63:22-24.

 

Rustfeld LO, Pavlik VN, Doody RS.

Hyperinsulinemia Type-2 Diabetes Mellitus and Cognitive Decline

Journal of the Texas Public Health Association 2008; 63:17-22.

 

Fairchild T.

Economic impact of AD in Texas

Journal of the Texas Public Health Association 2008; 63:5-8.

 

O’Bryant SE, Waring SC, Cullum CM, Hall JR, Lacritz LH, Massman PJ, Doody RS, Lupo P, Reisch J, and the Texas Alzheimer’s Research Consortium

Staging Dementia Severity with CDR Sum of Box Scores: An investigation by the Texas Alzheimer’s Disease Research Consortium

Archives of Clinical Neuropsychology 2007; 22:822.

 

 

 

 




Alzheimer's Facts

It costs Texas businesses an estimated $7 billion each year to provide health coverage for Alzheimer's patients and cover lost productivity in the workplace.